These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 13910649)

  • 1. Changes in bacterial enzyme patterns, drug susceptibility and chemotherapy through enzyme blocking agents.
    SENECA H; LATTIMER JK; ZINSSER HH; DONOVAN JT; PEER P; STUART PH
    J Urol; 1962 Mar; 87():495-8. PubMed ID: 13910649
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in bacterial enzyme patterns, drug susceptibility and chemotherapy through enzyme blocking agents.
    SENECA H; LATTIMER JK; ZINSSER JJ; DONOVAN JT; PEER P; STUART PH
    Trans Am Assoc Genitourin Surg; 1961; 53():188-95. PubMed ID: 13910650
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro screening and evaluation of some Indian medicinal plants for their potential to inhibit Jack bean and bacterial ureases causing urinary infections.
    Bai S; Bharti P; Seasotiya L; Malik A; Dalal S
    Pharm Biol; 2015 Mar; 53(3):326-33. PubMed ID: 25366133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemotherapy of urease- and citrase-producing bacteria of the urinary tract.
    SENECA H; LATTIMER JK; ZINSSER HH
    Ann Intern Med; 1960 Sep; 53():468-74. PubMed ID: 13750073
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of the Infected Stone.
    Marien T; Miller NL
    Urol Clin North Am; 2015 Nov; 42(4):459-72. PubMed ID: 26475943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited effectiveness of over-the-counter plant preparations used for the treatment of urinary tract infections as inhibitors of the urease activity from Staphylococcus saprophyticus.
    Deutch CE
    J Appl Microbiol; 2017 May; 122(5):1380-1388. PubMed ID: 28245081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review.
    Kosikowska P; Berlicki Ł
    Expert Opin Ther Pat; 2011 Jun; 21(6):945-57. PubMed ID: 21457123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ureases as a target for the treatment of gastric and urinary infections.
    Follmer C
    J Clin Pathol; 2010 May; 63(5):424-30. PubMed ID: 20418234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic treatment of infection stones.
    Bagley DH
    Urol Clin North Am; 1987 May; 14(2):347-52. PubMed ID: 3576856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small-molecular inhibitor against Proteus mirabilis urease to treat catheter-associated urinary tract infections.
    Milo S; Heylen RA; Glancy J; Williams GT; Patenall BL; Hathaway HJ; Thet NT; Allinson SL; Laabei M; Jenkins ATA
    Sci Rep; 2021 Feb; 11(1):3726. PubMed ID: 33580163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection stones and the role of bacterial urease.
    Rosenstein I; Hamilton-Miller JM; Brumfitt W
    J Infect; 1980 Sep; 2(3):211-4. PubMed ID: 6764484
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of urease activity in the urinary tract pathogens Staphylococcus saprophyticus and Proteus mirabilis by dimethylsulfoxide (DMSO).
    Deutch CE
    J Appl Microbiol; 2020 May; 128(5):1514-1523. PubMed ID: 31860153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of bacterial urease: microbiological considerations on hydroxyurea influenza virus.
    Perrone G; Ferrari C; Arghittu M
    Boll Ist Sieroter Milan; 1982; 61(6):513-5. PubMed ID: 6765400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi.
    Griffith DP; Gibson JR; Clinton CW; Musher DM
    J Urol; 1978 Jan; 119(1):9-15. PubMed ID: 23442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of urease activity in the urinary tract pathogen Staphylococcus saprophyticus.
    Loes AN; Ruyle L; Arvizu M; Gresko KE; Wilson AL; Deutch CE
    Lett Appl Microbiol; 2014 Jan; 58(1):31-41. PubMed ID: 24001038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Urease Enzyme Production and some Other Virulence Factors Expression in Proteus mirabilis by N-Acetyl Cysteine and Dipropyl Disulphide.
    Abdel-Baky RM; Ali MA; Abuo-Rahma GEAA; AbdelAziz N
    Adv Exp Med Biol; 2017; 973():99-113. PubMed ID: 28190143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flurofamide: a potent inhibitor of bacterial urease with potential clinical utility in the treatment of infection induced urinary stones.
    Millner OE; Andersen JA; Appler ME; Benjamin CE; Edwards JG; Humphrey DT; Shearer EM
    J Urol; 1982 Feb; 127(2):346-50. PubMed ID: 7038144
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acetylhydroxamic acid in the treatment of nephrolithiasis, caused by infection with urease forming microorganisms].
    Lorenz J; Lorenz K; Dabrowska B; Kowal R
    Z Urol Nephrol; 1989 Dec; 82(12):685-9. PubMed ID: 2698024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of bacterial urease.
    Griffith DP; Musher DM; Campbell JW
    Invest Urol; 1973 Nov; 11(3):234-8. PubMed ID: 4201416
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitors of urease as chemotherapeutic agents.
    Rosenstein IJ; Hamilton-Miller JM
    Crit Rev Microbiol; 1984; 11(1):1-12. PubMed ID: 6373150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.